Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Sanofi S.A.
Explore Sanofi
Core profile pages, annual revenue records, and related research hubs for this company.
Company History
Founded 2004 in Paris, France
Sanofi's modern company took shape in 2004 through the merger of Sanofi-Synthelabo and Aventis, while the original Sanofi lineage dates to 1973 inside Elf Aquitaine.
He helped build the original Sanofi lineage that later became part of the modern Sanofi group.
His role belongs to the pre-2004 Sanofi lineage rather than the legal formation of today's Sanofi S.A.
The original Sanofi business was founded in France as part of Elf Aquitaine.
Sanofi and Synthelabo combined, creating a stronger French pharmaceutical group.
Sanofi-Synthelabo and Aventis merged to form one of Europe's largest pharmaceutical companies.
Sanofi acquired Genzyme, strengthening its rare disease and specialty-care portfolio.
Dupixent became a major long-term growth driver in immunology through the Regeneron collaboration.
Sanofi completed a CEO transition from Paul Hudson to Belen Garijo.
Expanded Sanofi's rare disease and specialty medicine position.
Added targeted medicines and pipeline depth.
Sanofi is a Paris-based global biopharmaceutical company focused on medicines and vaccines. It reported EUR43.626 billion of net sales for FY2025.
Sanofi reported EUR43.626 billion of net sales for FY2025.
Yes. Sanofi reported EUR7.813 billion of net income attributable to equity holders for FY2025.
Belen Garijo is the CEO of Sanofi.